Immune cells injected into brain to fight tumors
NCT ID NCT07552233
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new treatment using natural killer (NK) cells, a type of immune cell, for adults with aggressive brain tumors that have not responded to standard therapies. The NK cells are grown in a lab and then given through a vein and directly into the brain. The main goal is to find a safe dose and see if it can shrink tumors or slow their growth.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Henan Academy of Innovations in Medical Science
RECRUITINGZhengzhou, Henan, 451162, China
-
Peking University Third Hospital
RECRUITINGBeijing, Beijing Municipality, 100191, China
-
Qinhuangdao Runze Hospital
NOT_YET_RECRUITINGQinhuangdao, Hebei, 066607, China
-
Zhengzhou Second Hospital
RECRUITINGZhengzhou, Henan, 450052, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New imaging clues could sharpen brain tumor monitoring
- Can a Custom-Made vaccine train the immune system to fight brain cancer?
- Can a virus injected into brain tumors fight recurrence?
- Can adding lenvatinib to standard care outsmart a tough brain cancer?
- Can a pill reach the brain and fight tumors?
- Can we predict frailty in serious illness? a large study investigates